PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activitySiyuan Zha, Fang Liu, Fei Wang et al.|Stem Cell Research & Therapy|2018Cited by 50
SIRT1 inhibits TGF‐β‐induced endothelial‐mesenchymal transition in human endothelial cells with Smad4 deacetylationZhen Li, Shuyan Chen, Siyuan Zha et al.|Journal of Cellular Physiology|2018Cited by 38